SynthesisInflammopharmacology2020

Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.

Mingjin Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.